Imaging of hypoxia with 18F-FAZA PET in patients with locally advanced non-small cell lung cancer treated with definitive chemoradiotherapy. (Q53101024)

From Wikidata

Jump to navigation Jump to search

scientific article published on 14 June 2013

Language	Label	Description	Also known as
English	Imaging of hypoxia with 18F-FAZA PET in patients with locally advanced non-small cell lung cancer treated with definitive chemoradiotherapy.	scientific article published on 14 June 2013

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/23870348

Imaging of hypoxia with 18F-FAZA PET in patients with locally advanced non-small cell lung cancer treated with definitive chemoradiotherapy. (English)

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/23870348

chemoradiotherapy

0 references

0 references

Rodney J. Hicks

12

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/23870348

9

object named as

David Binns

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/23870348

3

object named as

Danny Rischin

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/23870348

author name string

Mateya E Trinkaus

1

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/23870348

Rob Blum

2

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/23870348

Jason Callahan

4

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/23870348

Mathias Bressel

5

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/23870348

Tatiana Segard

6

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/23870348

Peter Roselt

7

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/23870348

Peter Eu

8

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/23870348

Michael P MacManus

10

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/23870348

David Ball

11

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/23870348

publication date

14 June 2013

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/23870348

Journal of Medical Imaging and Radiation Oncology

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/23870348

57

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/23870348

4

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/23870348

475-481

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/23870348

Drug resistance and the solid tumor microenvironment

1 reference

https://api.crossref.org/works/10.1111%2F1754-9485.12086

21 January 2018

Phase III trial of paclitaxel plus carboplatin with or without tirapazamine in advanced non-small-cell lung cancer: Southwest Oncology Group Trial S0003.

1 reference

https://api.crossref.org/works/10.1111%2F1754-9485.12086

21 January 2018

Tirapazamine plus cisplatin versus cisplatin in advanced non-small-cell lung cancer: A report of the international CATAPULT I study group. Cisplatin and Tirapazamine in Subjects with Advanced Previously Untreated Non-Small-Cell Lung Tumors.

1 reference

https://api.crossref.org/works/10.1111%2F1754-9485.12086

21 January 2018

Randomized phase II trial comparing nitroglycerin plus vinorelbine and cisplatin with vinorelbine and cisplatin alone in previously untreated stage IIIB/IV non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1111%2F1754-9485.12086

21 January 2018

Paclitaxel-carboplatin alone or with bevacizumab for non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1111%2F1754-9485.12086

21 January 2018

Pretreatment 18F-FAZA PET predicts success of hypoxia-directed radiochemotherapy using tirapazamine

1 reference

https://api.crossref.org/works/10.1111%2F1754-9485.12086

21 January 2018

Prognostic significance of [18F]-misonidazole positron emission tomography-detected tumor hypoxia in patients with advanced head and neck cancer randomly assigned to chemoradiation with or without tirapazamine: a substudy of Trans-Tasman Radiation O

1 reference

https://api.crossref.org/works/10.1111%2F1754-9485.12086

21 January 2018

Use of molecular biomarkers for predicting the response to radiotherapy with or without chemotherapy.

1 reference

https://api.crossref.org/works/10.1111%2F1754-9485.12086

21 January 2018

Imaging hypoxia in xenografted and murine tumors with 18F-fluoroazomycin arabinoside: a comparative study involving microPET, autoradiography, PO2-polarography, and fluorescence microscopy

1 reference

https://api.crossref.org/works/10.1111%2F1754-9485.12086

21 January 2018

Preparation of the hypoxia imaging PET tracer [18F]FAZA: reaction parameters and automation

1 reference

https://api.crossref.org/works/10.1111%2F1754-9485.12086

21 January 2018

Compliance with PET acquisition protocols for therapeutic monitoring of erlotinib therapy in an international trial for patients with non-small cell lung cancer.

1 reference

https://api.crossref.org/works/10.1111%2F1754-9485.12086

21 January 2018

Imaging of hypoxia in human tumors with [F-18]fluoromisonidazole

1 reference

https://api.crossref.org/works/10.1111%2F1754-9485.12086

21 January 2018

Marked, homogeneous, and early [18F]fluorodeoxyglucose-positron emission tomography responses to vemurafenib in BRAF-mutant advanced melanoma.

1 reference

https://api.crossref.org/works/10.1111%2F1754-9485.12086

21 January 2018

An evaluation of tumor oxygenation and gene expression in patients with early stage non-small cell lung cancers.

1 reference

https://api.crossref.org/works/10.1111%2F1754-9485.12086

21 January 2018

Hypoxia in models of lung cancer: implications for targeted therapeutics

1 reference

https://api.crossref.org/works/10.1111%2F1754-9485.12086

21 January 2018

Cellular uptake of PET tracers of glucose metabolism and hypoxia and their linkage.

1 reference

https://api.crossref.org/works/10.1111%2F1754-9485.12086

21 January 2018

Reproducibility of intratumor distribution of (18)F-fluoromisonidazole in head and neck cancer.

1 reference

https://api.crossref.org/works/10.1111%2F1754-9485.12086

21 January 2018

Identifiers

10.1111/1754-9485.12086

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/23870348

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/23870348

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q53101024&oldid=2109540710"